Sample Request

COVID-19 Outbreak-Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SELECT LICENSE:

Published on 01/19/2021| Code: MAR41115D| Category: Utilities| Total Pages: 122

A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Contract Research Organization (CRO) and CDMO for Pharmaceutical industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market can be split based on product types, major applications, and important countries as follows:

Key players in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market covered in Chapter 12:

PRA HEALTH SCIENCES, INC
Syneos Health Inc
SGS SA
Eurofins Scientific
Envigo
EPS INTERNATIONAL
IQVIA HOLDINGS INC
Charles River Laboratories, Inc
Medpace Holdings, Inc
GenScript Biotech Corporation
WuXi AppTec
PAREXEL International Corporation
Laboratory Corporation of America Holdings (LABCORP)
Pharmaceutical Product Development Inc
ICON PLC
EVOTEC AG

In Chapter 4 and 14.1, on the basis of types, the Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2015 to 2025 is primarily split into:

Protein Production & Purification Service
Antibody Production & Development Service
Transient Transfection CRO Service
Molecular Biology Service
Others

In Chapter 5 and 14.2, on the basis of applications, the Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2015 to 2025 covers:

Pharmaceutical and Biopharmaceutical Companies
Academic Institutes
Research Institutes
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Contract Research Organization (CRO) and CDMO for Pharmaceutical

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Contract Research Organization (CRO) and CDMO for Pharmaceutical industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size, 2015 – 2020

2.1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type, 2015 – 2020

2.1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application, 2015 – 2020

2.1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Contract Research Organization (CRO) and CDMO for Pharmaceutical Analysis

3.2 Major Players of Contract Research Organization (CRO) and CDMO for Pharmaceutical

3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Contract Research Organization (CRO) and CDMO for Pharmaceutical

3.3.3 Labor Cost of Contract Research Organization (CRO) and CDMO for Pharmaceutical

3.4 Market Distributors of Contract Research Organization (CRO) and CDMO for Pharmaceutical

3.5 Major Downstream Buyers of Contract Research Organization (CRO) and CDMO for Pharmaceutical Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Type

4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Market Share by Type (2015-2020)

4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Production and Market Share by Type (2015-2020)

4.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate by Type (2015-2020)

4.3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate of Protein Production & Purification Service
4.3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate of Antibody Production & Development Service
4.3.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate of Transient Transfection CRO Service
4.3.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate of Molecular Biology Service
4.3.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Value and Growth Rate of Others
4.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Price Analysis by Type (2015-2020)

5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, by Application

5.1 Downstream Market Overview

5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Market Share by Application (2015-2020)

5.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Growth Rate of Pharmaceutical and Biopharmaceutical Companies (2015-2020)
5.3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Growth Rate of Academic Institutes (2015-2020)
5.3.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Growth Rate of Research Institutes (2015-2020)
5.3.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption and Growth Rate of Others (2015-2020)

6 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Regions

6.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Regions

6.1.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Regions (2015-2020)

6.1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Regions (2015-2020)

6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

6.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

6.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

7 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Countries

7.2.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Countries (2015-2020)

7.2.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

7.3 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

7.4 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

7.5 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Countries

8.2.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Countries (2015-2020)

8.2.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

8.3 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8.4 UK Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8.5 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8.7 Spain Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

8.8 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Countries (2015-2020)

9.2.2 Asia Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

9.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9.4 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9.5 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9.6 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

9.8 Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

10 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

10.3 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

10.4 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

10.5 Egypt Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

10.6 Nigeria Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

10.7 South Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

11 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales, Revenue and Market Share by Countries

11.2.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales by Countries (2015-2020)

11.2.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Countries (2015-2020)

11.3 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

11.4 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

11.5 Columbia Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

11.6 Chile Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 PRA HEALTH SCIENCES, INC
12.1.1 PRA HEALTH SCIENCES, INC Basic Information
12.1.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.1.3 PRA HEALTH SCIENCES, INC Production, Value, Price, Gross Margin 2015-2020
12.2 Syneos Health Inc
12.2.1 Syneos Health Inc Basic Information
12.2.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.2.3 Syneos Health Inc Production, Value, Price, Gross Margin 2015-2020
12.3 SGS SA
12.3.1 SGS SA Basic Information
12.3.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.3.3 SGS SA Production, Value, Price, Gross Margin 2015-2020
12.4 Eurofins Scientific
12.4.1 Eurofins Scientific Basic Information
12.4.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.4.3 Eurofins Scientific Production, Value, Price, Gross Margin 2015-2020
12.5 Envigo
12.5.1 Envigo Basic Information
12.5.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.5.3 Envigo Production, Value, Price, Gross Margin 2015-2020
12.6 EPS INTERNATIONAL
12.6.1 EPS INTERNATIONAL Basic Information
12.6.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.6.3 EPS INTERNATIONAL Production, Value, Price, Gross Margin 2015-2020
12.7 IQVIA HOLDINGS INC
12.7.1 IQVIA HOLDINGS INC Basic Information
12.7.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.7.3 IQVIA HOLDINGS INC Production, Value, Price, Gross Margin 2015-2020
12.8 Charles River Laboratories, Inc
12.8.1 Charles River Laboratories, Inc Basic Information
12.8.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.8.3 Charles River Laboratories, Inc Production, Value, Price, Gross Margin 2015-2020
12.9 Medpace Holdings, Inc
12.9.1 Medpace Holdings, Inc Basic Information
12.9.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.9.3 Medpace Holdings, Inc Production, Value, Price, Gross Margin 2015-2020
12.10 GenScript Biotech Corporation
12.10.1 GenScript Biotech Corporation Basic Information
12.10.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.10.3 GenScript Biotech Corporation Production, Value, Price, Gross Margin 2015-2020
12.11 WuXi AppTec
12.11.1 WuXi AppTec Basic Information
12.11.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.11.3 WuXi AppTec Production, Value, Price, Gross Margin 2015-2020
12.12 PAREXEL International Corporation
12.12.1 PAREXEL International Corporation Basic Information
12.12.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.12.3 PAREXEL International Corporation Production, Value, Price, Gross Margin 2015-2020
12.13 Laboratory Corporation of America Holdings (LABCORP)
12.13.1 Laboratory Corporation of America Holdings (LABCORP) Basic Information
12.13.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.13.3 Laboratory Corporation of America Holdings (LABCORP) Production, Value, Price, Gross Margin 2015-2020
12.14 Pharmaceutical Product Development Inc
12.14.1 Pharmaceutical Product Development Inc Basic Information
12.14.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.14.3 Pharmaceutical Product Development Inc Production, Value, Price, Gross Margin 2015-2020
12.15 ICON PLC
12.15.1 ICON PLC Basic Information
12.15.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.15.3 ICON PLC Production, Value, Price, Gross Margin 2015-2020
12.16 EVOTEC AG
12.16.1 EVOTEC AG Basic Information
12.16.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Introduction
12.16.3 EVOTEC AG Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast

14.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Protein Production & Purification Service Market Value and Volume Forecast (2020-2025)
14.1.2 Antibody Production & Development Service Market Value and Volume Forecast (2020-2025)
14.1.3 Transient Transfection CRO Service Market Value and Volume Forecast (2020-2025)
14.1.4 Molecular Biology Service Market Value and Volume Forecast (2020-2025)
14.1.5 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Pharmaceutical and Biopharmaceutical Companies Market Value and Volume Forecast (2020-2025)
14.2.2 Academic Institutes Market Value and Volume Forecast (2020-2025)
14.2.3 Research Institutes Market Value and Volume Forecast (2020-2025)
14.2.4 Others Market Value and Volume Forecast (2020-2025)
14.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Mizuno corporation
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005